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In Japan, the number of patients with urolithiasis has continued to increase at a faster rate, with a
lifetime morbidity in 2005 of 15.1% for males and 6.8% for females, possibly due to : 1) westernization of
dietary habits and lifestyle, 2) improvement of diagnostic technologies (CT and ultrasound examination), and
3) aging of the population. Additionally, this disease has a higher recurrence rate ; for example,
approximately 50% for calcium-containing calculi. The guidelines on urolithiasis consist primarily of the
guidelines for treatment and recurrence prevention, and the items concerning recurrence prevention were
added in the 2007 updated Guidelines on Urolithiasis by the European Association of Urology (EAU) and the
American Urological Association (AUA) (EAU/AUA guidelines). These facts reflect the importance of
recurrence prevention. On the other hand, the Japanese guidelines on urolithiasis are now being revised
and will adopt the form of “clinical questions”. This paper provides an overview of the examination
methods for recurrence, lifestyle guidance, and drug therapies based on the current guidelines for diagnosis
and treatment of urolithiasis as well as the points for clinical questions to be included in the revised guidelines
for a deeper understanding and, consequently, return to routine clinical practice.
(Hinyokika Kiyo 58 : 707-711, 2012)















































































































































い．EAU/AUA ガイドラインでは16時間尿と 8 時間
尿蓄尿も記載されているがわが国では一般的ではな













る． 1日尿量を 2,000 ml 以上とするため食事以外に
1日 2,000 ml 以上の水分摂取を指導する． 4時間ご












































































































事指導に関係する CQ が 7題（飲水指導を主とした
CQ 2題，食事指導を主とした CQ 5題），薬物療法
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